1Uetrecht JP.New concepts in immunology relevant to idiosyncratic drug reactions:the"danger hypothesis"and innate immune system[J].J Chemical Res Toxicol,1999,12(5):387-395.
6Dean J.Drug hypersensitivity reactions in skin:understanding mechanisms and the development of diagnostic and predictive tests[J].J Toxical,2004,194(3):179-196.
7Janmohamed A,Dolphin CT,Phillips IR,et al.Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450[J].Biochem Pharmacol,2001,62(6):777-786.
8Bavdekar SB,Muranjan MN,Gogtay NJ,et al.Anticonvulsant hypersensitivity syndrome:lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment[J].Ann Pharmacother,2004,38(10):1648-1650.
9Green VJ,Pirmohamed M,Kitteringham NR,et al.Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity[J].Biochem Pharmacol,1995,50(9):1353-1359.
10Hashizume H,Takigawa M,Tokura Y.Character is action of drugs special T Cells in Phenobarbital-induced eruption[J].J Immunol,2002,168(10):5359-5368.
2Zaccara G,Franciotta D,Perncca E.Idiosyncratic adverse reactions to antiepileptic drugs[J].Epilepsia,2007,48(7):1223-1244.
3Chung WH,Hung SI,Hong HS,et al.A marker for Stevens-Johnson syndrome[J].Nature,2004,428(6892):486.
4Man CB,Kwan P,Baum L,et al.Association between HLA-B*1502 allele and antiepileptie drug-inducad cutaneous reactions in Han Chinese[J].Epilepsia,2007,48(5):1015-1018.
5Locharernkul C,Loplumlert J,Limotai C,et al.Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population[J].Epilepsia,2008,49(12):2087-2091.
6Ferrell PB Jr,McLeod HL.Carbamazepine,HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal neerolysis:US FDA recommendations[J].Pharmacogenomics,2008,9(10):1543-1546.
9Bunce M,O' Neill CM,Barnardo MC,et al.Hototyping:comprehensive DNA typing for HLA-A,B,C,DRB1,DRB3,DRB4,DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers(PCR-SSP)[J].Tissue Antigens,1995,46(5):355-367.
10Kaniwa N,Saito Y,Aihara M,et al.HLA-B locus in Japanese patients with anti-epileptics and allopurinolrelated Stevens-Johnson syndrome and toxic epidermal nccrolysis[J].Pharmacogenomics,2008,9(11):1617-1622.
1McCormaek M,Alfirevic A,Bourgeois S, et al. HLA-A" 3101 and carbamazepine-induced hypersensitivity reactions in Euro- peans[J]. N[JM, 2011,364(12) :1134-1143.
2Takeshi O.Genome-wide association study identifies HLA-A" 3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population[J]. Hum Mol Genet , 2011,20(5) :1034-1041.
3Kaniwa N,Saito Y,Aihara M, et al .HLA-B* 1511 is a risk factor for carbamazepine-induced Stvens-Johnson syndrome and toxic epidermal necrolysis in Japanese Patients [J]. Epilepsia, 2010,51(12) : 2461-2465.
